{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:36:20Z","timestamp":1790724980013,"version":"4.1.0"},"reference-count":57,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:p>G protein-coupled receptor kinase 2 (GRK2) is a serine\/theorinine kinase that phosphorylates and desensitizes agonist-bound G protein-coupled receptors. GRK2 is increased in expression and activity in lymphocytes and vascular smooth muscle (VSM) in human hypertension and animal models of the disease. Inhibition of GRK2 using the carboxyl-terminal portion of the protein (GRK2ct) has been an effective tool to restore compromised \u03b2-adrenergic receptor (AR) function in heart failure and improve outcome. A well-characterized dysfunction in hypertension is attenuation of \u03b2AR-mediated vasodilation. Therefore, we tested the role of inhibition of GRK2 using GRK2ct or VSM-selective GRK2 gene ablation in a renal artery stenosis model of elevated blood pressure (BP) [the two-kidney, one-clip (2K1C) model]. Use of the 2K1C model resulted in a 30% increase in conscious BP, a threefold increase in plasma norepinephrine levels, and a 50% increase in VSM GRK2 mRNA levels. BP remained increased despite VSM-specific GRK2 inhibition by either GRK2 knockout (GRK2KO) or peptide inhibition (GRK2ct). Although \u03b2AR-mediated dilation in vivo and in situ was enhanced, \u03b1<jats:sub>1<\/jats:sub>AR-mediated vasoconstriction was also increased. Further pharmacological experiments using \u03b1<jats:sub>1<\/jats:sub>AR antagonists revealed that GRK2 inhibition of expression (GRK2KO) or activity (GRK2ct) enhanced \u03b1<jats:sub>1D<\/jats:sub>AR vasoconstriction. This is the first study to suggest that VSM \u03b1<jats:sub>1D<\/jats:sub>ARs are a GRK2 substrate in vivo.<\/jats:p>","DOI":"10.1152\/ajpheart.00564.2008","type":"journal-article","created":{"date-parts":[[2008,8,23]],"date-time":"2008-08-23T01:09:29Z","timestamp":1219453769000},"page":"H1695-H1704","source":"Crossref","is-referenced-by-count":46,"title":["Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances \u03b1<sub>1D<\/sub>-adrenergic receptor constriction"],"prefix":"10.1152","volume":"295","author":[{"given":"Heather Irina","family":"Cohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pesant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"2nd","given":"Gerald W.","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Eckhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.5.955"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-999-0005-x"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2180"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00065.2001"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15981.x"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001356"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.1.43"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1124\/mol.61.4.749"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1996.271.4.H1599"},{"key":"R10","unstructured":"Esler M.Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.J Hypertens Suppl20: S13\u2013S19, 2002."},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(98)00022-X"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-3-6"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.609"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119381"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.35.1.38"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70074-3"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2006.03.004"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00880.2007"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706325"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703097"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(00)88992-6"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000035397.73223.CE"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1210\/rp.59.1.13"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.531657"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409532102"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1023\/B:MCBI.0000041843.64809.48"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12706"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Koch WJ, Inglese J, Stone WC, Lefkowitz RJ.The binding site for the \u03b2\u03b3 subunits of heterotrimeric G proteins on the \u03b2-adrenergic receptor kinase.J Biol Chem268: 8256\u20138260, 1993.","DOI":"10.1016\/S0021-9258(18)53090-8"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1126\/science.7761854"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000247932.71270.2c"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.09.021"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.414-429.2004"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1021\/jm060358r"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.09.011"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(00)00053-0"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(03)00243-8"},{"key":"R38","unstructured":"Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, Perez DM.The specific contribution of the novel \u03b1-1Dadrenoceptor to the contraction of vascular smooth muscle.J Pharmacol Exp Ther275: 1583\u20131589, 1995."},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5451-2"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1038\/415206a"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1153"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.132552699"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Russell A, Watts S.Vascular reactivity of isolated thoracic aorta of the C57BL\/6J mouse.J Pharmacol Exp Ther294: 598\u2013604, 2000.","DOI":"10.1016\/S0022-3565(24)39111-6"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.10.1047"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2001.281.1.F172"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btg157"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.5.1157"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000022062.70639.1C"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200214001"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Uberti MA, Hague C, Oller H, Minneman KP, Hall RA.Heterodimerization with \u03b22-adrenergic receptors promotes surface expression and functional activity of \u03b11D-adrenergic receptors.J Pharmacol Exp Ther313: 16\u201323, 2005.","DOI":"10.1124\/jpet.104.079541"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00781-4"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-0128(99)00047-0"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708912200"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.29.4.1025"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2007.04707.x"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00054.2002"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01134-7"}],"container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpheart.00564.2008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:02:07Z","timestamp":1738342927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpheart.00564.2008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1152\/ajpheart.00564.2008"],"URL":"https:\/\/doi.org\/10.1152\/ajpheart.00564.2008","relation":{},"ISSN":["0363-6135","1522-1539"],"issn-type":[{"value":"0363-6135","type":"print"},{"value":"1522-1539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}